Psychoeducation for Chronic Disease Management in Re-entered Seniors

(SRRS Trial)

Overseen By Stephanie Grace Prost, PhD

Age: 18+

Sex: Male

Trial Phase: Academic

Sponsor: University of Louisville

Disqualifiers: Age 44 or younger, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 8

8 Participants Needed

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It seems focused on education and skill-building, so it's unlikely that medication changes are required.

What data supports the effectiveness of the treatment Psychoeducation for managing chronic diseases in seniors?

Research shows that therapeutic patient education, which includes psychoeducation, is effective in helping people manage chronic diseases by improving their knowledge and skills, leading to better daily management and quality of life. This approach has been successful in various chronic conditions, including diabetes and hypertension, by involving patients actively in their care. ^{1 2 3 4 5}

Is psychoeducation safe for humans?

Psychoeducation has been used safely in various conditions like psychotic disorders, depression, and breast cancer, with no major safety concerns reported in the studies. ^{6 7 8 9 10}

How is the treatment Psychoeducation unique for managing chronic diseases in seniors?

Psychoeducation is unique because it focuses on educating patients about their condition, helping them understand and manage their disease better by providing information and skills, which empowers them to take an active role in their care. Unlike other treatments that may focus solely on medication or physical interventions, psychoeducation emphasizes the psychological and educational aspects, aiming to improve patients' autonomy and quality of life. ^{2 6 11 12 13}

What is the purpose of this trial?

The first goal (Aim 1) of this clinical trial is to learn about specific strengths, challenges, and desired areas of knowledge and skill-building among older adults who re-entered their communities from a period of incarceration and to then develop a new psychoeducational intervention tailored to these older adults. The second goal (Aim 2) of this clinical trial is to test if the intervention increases chronic disease management and whether the intervention is considered appropriate and acceptable by older adults who re-entered their communities from a period of incarceration. Aim 1 participants will: * complete a baseline survey * participate in a focus group Aim 2 participants will: * complete a baseline survey * participate in an 8-week once weekly intervention * complete three follow up surveys

Eligibility Criteria

This trial is for older adults, aged 45 and above, who have recently re-entered the community from jail or prison. Participants must have at least one chronic health condition and be able to speak and understand English.

Inclusion Criteria

Able to speak and understand English

Have re-entered the community from a period of incarceration from jail or prison

Have at least one chronic health condition

Exclusion Criteria

Does not have at least one chronic health condition

Have not re-entered the community from a period of incarceration from jail or prison

Unable to speak and understand English

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Baseline Assessment

Participants complete a baseline survey and participate in a focus group

1-2 weeks

Intervention

Participants engage in an 8-week psychoeducational intervention, meeting once weekly

8 weeks

8 visits (in-person)

Follow-up

Participants complete three follow-up surveys to assess the intervention's impact on chronic disease management

4 weeks

Treatment Details

Interventions

• Psychoeducation

Trial Overview The study aims to develop a psychoeducational program tailored for these seniors to help manage their chronic diseases better. It will test if this new intervention improves disease management and assess its appropriateness and acceptance among participants.

Participant Groups

Group I: Supporting resilience psychoeducational group Experimental Treatment 1 Intervention

This group-based psychoeducational intervention will take place once weekly for eight weeks and will be centered upon building older adults' knowledge, skills, and motivation to manage chronic disease.

Who Is Running the Clinical Trial?

University of Louisville

Lead Sponsor

Trials

353

Recruited

76,400+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials

2,658

Recruited

3,409,000+

Findings from Research

Patient education programs can significantly enhance self-management of chronic illnesses like diabetes, which is crucial for prevention and lifestyle modification.

Evaluating the effectiveness of these programs is complex due to various influencing factors, including patient demographics, disease characteristics, and healthcare system dynamics, all of which must be considered in research design.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Measures and methods in evaluating patient education programs for chronic illness. Lane, DS., Evans, D.[2019]

A 20-session group psychoeducation program significantly increased knowledge among 99 patients with psychotic disorders, with improvements noted immediately and sustained for at least 6 months after the program.

Coping skills improved during the program but did not show lasting effects beyond the immediate post-program period, indicating that while psychoeducation enhances knowledge, its impact on coping may be temporary.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Psychoeducation for patients with a psychotic disorder: effects on knowledge and coping. Bossema, ER., de Haar, CA., Westerhuis, W., et al.[2021]

Psychoeducation significantly reduced anxiety levels and improved the quality of life (QoL) for women with breast cancer, based on a meta-analysis of 27 randomized controlled trials involving 7742 participants.

However, psychoeducation did not show a significant impact on adherence to diagnostic procedures, treatment, depression, or breast cancer knowledge, indicating its benefits may be more focused on emotional support rather than treatment compliance.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Psychoeducation for breast cancer: A systematic review and meta-analysis. Setyowibowo, H., Yudiana, W., Hunfeld, JAM., et al.[2022]

Psychoeducation has been effectively used for over 20 years to support families of patients with psychiatric illnesses, and adapting this approach for patients themselves has shown positive effects on their functioning and attitudes.

The psychoeducation model aims to enhance patients' understanding of their psychiatric conditions and treatments, encourage group discussions for better integration of knowledge, and teach management skills to help them cope with their illnesses.

NCBI (Pubmed)

pubmed.ncbi.nlm.nih.gov

Patient psychoeducation: the therapeutic use of knowledge for the mentally ill. Hayes, R., Gantt, A.[2015]

References

1. United States pubmed.ncbi.nlm.nih.gov

Measures and methods in evaluating patient education programs for chronic illness. [2019]

2. France pubmed.ncbi.nlm.nih.gov

[Psychology in therapeutic patient education]. [2021]

3. France pubmed.ncbi.nlm.nih.gov

[Patient education in geriatrics: which specificities?]. [2016]

4. Mexico pubmed.ncbi.nlm.nih.gov

[Clinical control after diabetic and hypertension therapy group sessions]. [2015]

5. Switzerland pubmed.ncbi.nlm.nih.gov

Effectiveness of therapeutic patient education interventions for chronic diseases: A systematic review and meta-analyses of randomized controlled trials. [2023]

6. Czech Republic pubmed.ncbi.nlm.nih.gov

Psychoeducation for psychotic patients. [2018]

7. India pubmed.ncbi.nlm.nih.gov

Effect of psychoeducation on short-term outcome in patients with late life depression: A randomized control trial - Protocol. [2022]

8. United States pubmed.ncbi.nlm.nih.gov

Psychoeducation for patients with a psychotic disorder: effects on knowledge and coping. [2021]

9. Netherlands pubmed.ncbi.nlm.nih.gov

Psychoeducation for breast cancer: A systematic review and meta-analysis. [2022]

10. England pubmed.ncbi.nlm.nih.gov

Coping with depression and anxiety: preliminary results of a standardized course for elderly depressed women. [2019]

11. England pubmed.ncbi.nlm.nih.gov

Frequency and relevance of psychoeducation in psychiatric diagnoses: results of two surveys five years apart in German-speaking European countries. [2021]

12. United States pubmed.ncbi.nlm.nih.gov

Patient psychoeducation: the therapeutic use of knowledge for the mentally ill. [2015]

13. United States pubmed.ncbi.nlm.nih.gov

Psychoeducational interventions in rheumatic diseases: a review of papers published from September 2001 to August 2002. [2019]